Table 3.

Neutralizing antibodies among cases and controls vaccinated with the ChAdOx1 CoV-19 vaccine

Variables	WM(n = 16)	Controls(n = 38)	P
NAb, day 1 (%)	16 ± 10	16.3 ± 9.7	.9
NAb, day 22 (%)	17.3 ± 2.4	34.6 ± 3.7	.005
NAb, day 50 (%)	21.8 ± 2.6	45.5 ± 3.8	<.001
Percentage over 30% NAb, day 1	6.3%	3.9%	.7
Percentage over 30% NAb, day 22	12.5%	52.6%	.006
Percentage over 50% NAb, day 22	0%	29%	.016
Percentage over 30% NAb, day 50	23%	68.4%	.004
Percentage over 50% NAb, day 50	0%	44.7%	.003

 Values are expressed as median ± IQR or as percentages (%). Bold values denote statistical significance.